Growth plate cartilage as developmental model in osteoarthritis research - Potentials and limitations

被引:17
作者
Aigner, T.
Gerwin, N.
机构
[1] Univ Leipzig, Inst Pathol, D-0341 Leipzig, Germany
[2] Novartis Inst BioMed Res, Bone & Cartilage Program, Basel, Switzerland
关键词
drug development; chondrocytes; SOX; MMP; cartilage; collagen degradation;
D O I
10.2174/138945007779940052
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gene expression analysis including large scale gene expression profiling has become a very basic tool for investigating the pathogenesis of degenerative joint diseases as well as for the search of new drug targets. However, gene expression analysis so far revealed very complex expression patterns rather than a clear picture of molecular changes occurring during the initiation and progression of the disease. To elucidate the molecular changes in osteoarthritis the analysis of the fetal growth plate as a developmental model for phenotypic changes in chondrocytes occurring in osteoarthritis can help in three ways: it allows to interpret gene expression patterns in the context of disease-relevant processes also occurring in developing cartilage (e.g. cell differentiation, proliferation, matrix synthesis, catabolism and calcification), it offers the chance to investigate gene function in these functional contexts by knocking out or overexpressing genes in animals, and it provides a suitable model for testing the effect of therapeutic compounds on these processes within the growing cartilage.
引用
收藏
页码:377 / 385
页数:9
相关论文
共 98 条
  • [1] Aigner T, 1999, ARTHRITIS RHEUM, V42, P1443, DOI 10.1002/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO
  • [2] 2-A
  • [3] Functional genomics of osteoarthritis - On the way to evaluate disease hypotheses
    Aigner, T
    Bartnik, E
    Sohler, F
    Zimmer, R
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (427) : S138 - S143
  • [4] ACTIVATION OF COLLAGEN TYPE-II EXPRESSION IN OSTEOARTHRITIC AND RHEUMATOID CARTILAGE
    AIGNER, T
    STOSS, H
    WESELOH, G
    ZEILER, G
    VONDERMARK, K
    [J]. VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1992, 62 (06) : 337 - 345
  • [5] Molecular pathology and pathobiology of osteoarthritic cartilage
    Aigner, T
    McKenna, L
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (01) : 5 - 18
  • [6] Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO
  • [7] 2-H
  • [8] Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: A hypothesis
    Aigner, T
    Dudhia, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (05) : 287 - 291
  • [9] Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage
    Aigner, T
    Vornehm, SI
    Zeiler, G
    Dudhia, J
    vonderMark, K
    Bayliss, MT
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (03): : 562 - 569
  • [10] INDEPENDENT EXPRESSION OF FIBRIL-FORMING COLLAGEN-I, COLLAGEN-II, AND COLLAGEN-III IN CHONDROCYTES OF HUMAN OSTEOARTHRITIC CARTILAGE
    AIGNER, T
    BERTLING, W
    STOSS, H
    WESELOH, G
    VONDERMARK, K
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) : 829 - 837